FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to obstetrics, and may be used for preventing preeclampsia. To do this, patients with risk factors for preeclampsia immediately after establishing the fact of pregnancy are given the drug duphaston at the dosage of 10 mg 2 times a day every day until the 20th week of pregnancy with a dose reduction to 10 mg per day for the 21st week followed by cancellation. Then the drug is administered in the dosage of 225 mg daily up to the 11th week of pregnancy, inclusive, and starting from the 12th week it is replaced with the drug aspirin 75 mg daily before delivery.
EFFECT: method allows to increase the effectiveness of preventing the development of preeclampsia due to its simplicity and convenience.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SEVERE GESTOSIS PROPHYLAXIS | 2010 |
|
RU2440815C1 |
| METHOD FOR PREECLAMPSIA PREVENTION | 2011 |
|
RU2472506C1 |
| METHOD FOR PREVENTING PRETERM BIRTH | 2015 |
|
RU2578478C1 |
| METHOD FOR PREDICTION OF DEVELOPING SEVERE PREECLAMPSIA | 2012 |
|
RU2481578C1 |
| METHOD FOR COAGULOPATIC BLEEDING PREVENTION DURING CESAREAN SECTION | 2016 |
|
RU2629040C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PREECLAMPSIA (PE) IN FIRST TRIMESTER OF PREGNANCY | 2024 |
|
RU2821130C1 |
| METHOD FOR FETOPLACENTAL INSUFFICIENCY PREVENTION FOR PREGNANT WOMEN WITH CHRONIC KIDNEY DISEASE | 2016 |
|
RU2623064C1 |
| METHOD FOR PREVENTING SEVERE PREGNANCY COMPLICATIONS IN THROMBOPHILIC PATIENTS | 2008 |
|
RU2367446C1 |
| METHOD FOR PREVENTING PLACENTAL DYSFUNCTION IN ACUTE GESTATIONAL PYELONEPHRITIS | 2018 |
|
RU2694514C1 |
| METHOD OF PROLONGING PREGNANCY IN EARLY PRE-ECLAMPSIA | 2023 |
|
RU2803574C1 |
